Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Association of calpain-10 gene polymorphism and posttransplant diabetes mellitus in kidney transplant patients medicated with tacrolimus

The Pharmacogenomics Journal volume 10, pages 120–125 (2010)Cite this article

Abstract

New-onset, posttransplant diabetes mellitus (PTDM) has a high incidence after kidney transplantation in patients medicated with tacrolimus, and may adversely affect the patient and graft survival. The pathophysiology of PTDM closely mimics that of type II diabetes mellitus (T2DM). One of possible genetic factors predisposing to PTDM might be polymorphism in calpain-10 gene (CAPN10), previously associated with increased risk of T2DM in general population. Therefore, the present study was aimed at evaluation of CAPN10 gene polymorphisms in PTDM in kidney transplant patients medicated with tacrolimus. A total of 214 nondiabetic kidney transplant patients medicated with tacrolimus (56 patients with PTDM and 158 patients without PTDM were genotyped for the presence of CAPN10 gene variants (SNP-43: rs3792267:G>A, SNP-19: rs3842570 ins/del and SNP-63: rs5030952:C>T) using PCR-based assays. Frequency of SNP-63 minor allele was slightly increased in PTDM patients (P=0.056), and an association of SNP-63 heterozygosity and the risk of PTDM (odds ratios (OR)=2.45, P=0.023) was observed. An increased odds for PTDM development in patients carrying 1-1-2 haplotype (rs3792267:G-rs3842570:ins-rs5030952:T) compared to noncarriers was also noted (OR=2.35, P=0.026). Patients’ higher body mass index and SNP-63 minor T allele carrier status were identified as independent PTDM risk factors, confirmed by multivariate regression analysis. This is the first study of CAPN10 polymorphism in relation to PTDM risk. However, the application of SNP-63 (rs5030952:C>T) as a marker of PTDM should be verified by further independent studies.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Markell M . New-onset diabetes mellitus in transplant patients: pathogenesis, complications, and management. Am J Kidney Dis 2004; 43: 953–965.

    Article  PubMed  Google Scholar 

  2. Moore R, Ravindran V, Baboolal K . The burden of new-onset diabetes mellitus after transplantation. Clin Transplant 2006; 20: 755–761.

    Article  PubMed  Google Scholar 

  3. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ . Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003; 3: 178–185.

    Article  PubMed  Google Scholar 

  4. Davidson J, Wilkinson A, Dantal J, Dotta F, Haller H, Hernández D et al. New-onset diabetes after transplantation: 2003 international consensus guidelines. Transplantation 2003; 75 (Suppl 10): SS3.

    Google Scholar 

  5. Kahn SE . The relative contributions of insulin resistance and beta cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 2003; 46: 3–19.

    Article  CAS  Google Scholar 

  6. Ekstrand AV, Eriksson JG, Gronhagen-Riska C, Ahonen PJ, Groop LC . Insulin resistance and insulin deficiency in the pathogenesis of post-transplantation diabetes in man. Transplantation 1992; 53: 563–569.

    Article  CAS  Google Scholar 

  7. Numakura K, Satoh S, Tsuchiya N, Horikawa Y, Inoue T, Kakinuma H et al. Clinical and genetic risk factors for posttransplant diabetes mellitus in adult renal transplant recipients treated with tacrolimus. Transplantation 2005; 80: 1419–1424.

    Article  CAS  PubMed  Google Scholar 

  8. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 2000; 26: 163–175.

    Article  CAS  PubMed  Google Scholar 

  9. Carlsson E, Poulsen P, Storgaard H, Almgren P, Ling C, Jensen CB et al. Genetic and nongenetic regulation of CAPN10 mRNA in skeletal muscle. Diabetes 2005; 54: 3015–3020.

    Article  CAS  PubMed  Google Scholar 

  10. Baier LJ, Permana PA, Yang X, Pratley RE, Hanson RL, Shen GQ et al. A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. J Clin Invest 2000; 106: R69–R73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Tsuchiya T, Yan H, Vogelstein B, Kinzler K, Bell GI . Identification of a haplotype associated with the decreased expression of calpain-10 in lymophoblastoid cell lines. Diabetes 2003; 52: A256.

    Google Scholar 

  12. Weedon MN, Schwarz PE, Horikawa Y, Iwasaki N, Illig T, Holle R et al. Meta-analysis and a large association study confirm a role for calpain-10 variation in type 2 diabetes susceptibility. Am J Hum Genet 2003; 73: 1208–1212.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Song Y, Niu T, Manson JE, Kwiatkowski DJ, Liu S . Are variants in the CAPN10 gene related to risk of type 2 diabetes? A Quantitative Assessment of Population and family-based association studies. Am J Hum Genet 2004; 74: 208–222.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Hoffstedt J, Näslund E, Arner P . Calpain-10 gene polymorphism is associated with reduced beta(3)-adrenoceptor function in human fat cells. J Clin Endocrinol Metab 2002; 87: 3362–3367.

    CAS  PubMed  Google Scholar 

  15. Malecki MT, Moczulski DK, Klupa T, Wanic K, Cyganek K, Frey J et al. Homozygous combination of calpain 10 gene haplotypes is associated with type 2 diabetes mellitus in a Polish population. Eur J Endocrinol 2002; 146: 695–699.

    Article  PubMed  Google Scholar 

  16. Montori VM, Basu A, Erwin PJ, Velosa JA, Gabriel SE, Kudva YC . Posttransplantation diabetes: a systematic review of the literature. Diabetes Care 2002; 25: 583–592.

    Article  Google Scholar 

  17. van Hooff JP, Christiaans MH, van Duijnhoven EM . Tacrolimus and posttransplant diabetes mellitus in renal transplantation. Transplantation 2005; 79: 1465–1469.

    Article  CAS  PubMed  Google Scholar 

  18. Shah T, Kasravi A, Huang E, Hayashi R, Young B, Cho YW et al. Risk factors for development of new-onset diabetes mellitus after transplantation. Transplantation 2006; 82: 1673–1676.

    Article  Google Scholar 

  19. Sulanc E, Lane JT, Puumala SE, Groggel GC, Wrenshall LE, Stevens RB . New-onset diabetes mellitus after kidney transplantation: an application of 2003 international guidelines. Transplantation 2005; 80: 945–952.

    Article  PubMed  Google Scholar 

  20. Hamer RA, Chow CL, Ong AC, MacKane WS . Polycystic kidney disease is a risk factor for new-onset diabetes after transplantation. Transplantation 2007; 83: 36–40.

    Article  PubMed  Google Scholar 

  21. Rodrigo E, Pinera C, de Cos MA, Sanchez B, Ruiz JC, Fernandez-Fresnedo G et al. Evolution of tacrolimus blood levels and concentration-dose ratios in patients who develop new onset diabetes mellitus after kidney transplantation. Transplant Int 2005; 18: 1152–1157.

    Article  Google Scholar 

  22. Lynn S, Evans JC, White C, Frayling TM, Hattersley AT, Turnbull DM et al. Variation in the calpain-10 gene affects blood glucose levels in the British population. Diabetes 2002; 51: 247–250.

    Article  CAS  PubMed  Google Scholar 

  23. Polychronakos C . Common and rare alleles as causes of complex phenotypes. Curr Atheroscler Rep 2008; 10: 194–200.

    Article  CAS  PubMed  Google Scholar 

  24. Horikawa Y . Calpain-10 (NIDDM1) as a susceptibility gene for common type 2 diabetes. Endocr J 2006; 53: 567–576.

    Article  CAS  PubMed  Google Scholar 

  25. Tsuchiya T, Schwarz PE, Bosque-Plata LD, Geoffrey Hayes M, Dina C, Froguel P et al. Association of the calpain-10 gene with type 2 diabetes in Europeans: results of pooled and meta-analyses. Mol Genet Metab 2006; 89: 174–184.

    Article  CAS  PubMed  Google Scholar 

  26. Cox NJ, Hayes MG, Roe CA, Tsuchiya T, Bell GI . Linkage of calpain 10 to type 2 diabetes: the biological rationale. Diabetes 2004; 53 (Suppl 1): S19–S25.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, Pomeranian Medical University, Szczecin, Poland

    Mateusz Kurzawski, Wanda Gornik, Anna Banas & Marek Drozdzik

  2. Clinical Department of Nephrology and Dialysis, Regional Hospital, Szczecin, Poland

    Krzysztof Dziewanowski

  3. Department of Nephrology, Transplantation and Internal Medicine, Pomeranian Medical University, Szczecin, Poland

    Karolina Kedzierska

Authors
  1. Mateusz Kurzawski
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Krzysztof Dziewanowski
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Karolina Kedzierska
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wanda Gornik
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Anna Banas
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Marek Drozdzik
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marek Drozdzik.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kurzawski, M., Dziewanowski, K., Kedzierska, K. et al. Association of calpain-10 gene polymorphism and posttransplant diabetes mellitus in kidney transplant patients medicated with tacrolimus. Pharmacogenomics J 10, 120–125 (2010). https://doi.org/10.1038/tpj.2009.44

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/tpj.2009.44

Keywords

This article is cited by

Search

Advanced search

Quick links